Xia Sheng Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Xia Sheng Hu has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Aniqa Hasan
Melbourne Dental School, The University of Melbourne, 720 Swanston Street, Carlton, VIC 3053, Australia
1 shared publication - Antonio Celentano
Melbourne Dental School, The University of Melbourne
1 shared publication - Federica Canfora
Department of Neuroscience, Reproductive Sciences and Dentistry, University of Naples Federico II, Naples, Italy
1 shared publication - Henry C. Owuama
Melbourne Dental School, The University of Melbourne, 720 Swanston Street, Carlton, VIC 3053, Australia
1 shared publication - Hidetada Sasaki
Sendai Tomizawa Hospital Sendai Japan
1 shared publication - Hiroyuki Arai
Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan
1 shared publication
Latest Publications
- Open Access
- 10 June 2023
- Published by MDPI AG in Biomolecules
- Vol. 13 (6) , 973
In Vitro Cytotoxicity of Antiresorptive and Antiangiogenic Compounds on Oral Tissues Contributing to MRONJ: Systematic Review
Background: Invasive dental treatment in patients exposed to antiresorptive and antiangiogenic drugs can cause medication-related osteonecrosis of the jaw (MRONJ). Currently, the exact pathogenesis of this disease is unclear. Methods: In March 2022, Medline (Ovid), Embase (Ovid), Scopus, and Web of Science were screened to identify eligible in vitro studies investigating the effects of antiresorptive and antiangiogenic compounds on orally derived cells. Results: Fifty-nine articles met the inclusion criteria. Bisphosphonates were used in 57 studies, denosumab in two, and sunitinib and bevacizumab in one. Zoledronate was the most commonly used nitrogen-containing bisphosphonate. The only non-nitrogen-containing bisphosphonate studied was clodronate. The most frequently tested tissues were gingival fibroblasts, oral keratinocytes, and alveolar osteoblasts. These drugs caused a decrease in cell proliferation, viability, and migration. Conclusions: Antiresorptive and antiangiogenic drugs displayed cytotoxic effects in a dose and time-dependent manner. Additional research is required to further elucidate the pathways of MRONJ.
- 10 June 2023
- Published by MDPI AG in Biomolecules
- Vol. 13 (6) , 973
Open AccessIn Vitro Cytotoxicity of Antiresorptive and Antiangiogenic Compounds on Oral Tissues Contributing to MRONJ: Systematic Review
Background: Invasive dental treatment in patients exposed to antiresorptive and antiangiogenic drugs can cause medication-related osteonecrosis of the jaw (MRONJ). Currently, the exact pathogenesis of this disease is unclear. Methods: In March 2022, Medline (Ovid), Embase (Ovid), Scopus, and Web of Science were screened to identify eligible in vitro studies investigating the effects of antiresorptive and antiangiogenic compounds on orally derived cells. Results: Fifty-nine articles met the inclusion criteria. Bisphosphonates were used in 57 studies, denosumab in two, and sunitinib and bevacizumab in one. Zoledronate was the most commonly used nitrogen-containing bisphosphonate. The only non-nitrogen-containing bisphosphonate studied was clodronate. The most frequently tested tissues were gingival fibroblasts, oral keratinocytes, and alveolar osteoblasts. These drugs caused a decrease in cell proliferation, viability, and migration. Conclusions: Antiresorptive and antiangiogenic drugs displayed cytotoxic effects in a dose and time-dependent manner. Additional research is required to further elucidate the pathways of MRONJ.
- Open Access
- 1 January 2000
- Published by The Japan Geriatrics Society in Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics
- Vol. 37 (12) , 974-978
Prediction of Progression in Patients with Mild Cognitive Impairment Using IMP-SPECT.
記憶障害が存在するもののその他の認知機能はおおむね正常で, 自立した日常生活が継続できるような段階は, Mild cognitive impairment (MCI) という名称で, 近年定義づけられ, Alzheimer 病 (AD)の発症予備群と考えられている. そこでMCIと正常加齢の脳機能画像上の違いを明らかにする目的で, 19名のMCI患者, 23名のAD患者, 15名の正常高齢者において, IMP-SPECTを用いて局所脳血流の測定を行った. 平均MMSEスコアは, MCI群が25.3±1.2 (mean±SD), AD群が17.5±3.3であった. 後帯状回, 前頭葉, 側頭葉, 頭頂葉に関心領域 (ROI) を設定し, 小脳のROI値に基づいて標準化して, 脳血流比を算出した. また Statistical Parametric Mapping (SPM) を使用して, ボクセル単位での画像比較も行った. その結果, 後帯状回における局所脳血流比は正常高齢者群と比較して, MCI群 (0.956±0.080), AD群 (0.833±0.118) ともに有意に低下していた. その他の領域の局所脳血流比は, AD群と正常高齢者群との間でのみ有意差を認めた. 後帯状回局所脳血流比を用いて正常高齢者とMCI患者を鑑別する場合, 特異度を80%に設定した際の感度は80.5%であった. SPMにより, 正常高齢者とMCI患者の脳血流画像を比較すると, ROI解析と同様に, 後帯状回においてのみ有意差を認めた. 以上の結果から, 後帯状回の脳血流低下を示すMCI患者はADへ進行する危険性が高いことが示唆され, 脳血流画像からMCI患者のADへの進行を予測可能であることが確認された.
- 1 January 2000
- Published by The Japan Geriatrics Society in Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics
- Vol. 37 (12) , 974-978
Open AccessPrediction of Progression in Patients with Mild Cognitive Impairment Using IMP-SPECT.
記憶障害が存在するもののその他の認知機能はおおむね正常で, 自立した日常生活が継続できるような段階は, Mild cognitive impairment (MCI) という名称で, 近年定義づけられ, Alzheimer 病 (AD)の発症予備群と考えられている. そこでMCIと正常加齢の脳機能画像上の違いを明らかにする目的で, 19名のMCI患者, 23名のAD患者, 15名の正常高齢者において, IMP-SPECTを用いて局所脳血流の測定を行った. 平均MMSEスコアは, MCI群が25.3±1.2 (mean±SD), AD群が17.5±3.3であった. 後帯状回, 前頭葉, 側頭葉, 頭頂葉に関心領域 (ROI) を設定し, 小脳のROI値に基づいて標準化して, 脳血流比を算出した. また Statistical Parametric Mapping (SPM) を使用して, ボクセル単位での画像比較も行った. その結果, 後帯状回における局所脳血流比は正常高齢者群と比較して, MCI群 (0.956±0.080), AD群 (0.833±0.118) ともに有意に低下していた. その他の領域の局所脳血流比は, AD群と正常高齢者群との間でのみ有意差を認めた. 後帯状回局所脳血流比を用いて正常高齢者とMCI患者を鑑別する場合, 特異度を80%に設定した際の感度は80.5%であった. SPMにより, 正常高齢者とMCI患者の脳血流画像を比較すると, ROI解析と同様に, 後帯状回においてのみ有意差を認めた. 以上の結果から, 後帯状回の脳血流低下を示すMCI患者はADへ進行する危険性が高いことが示唆され, 脳血流画像からMCI患者のADへの進行を予測可能であることが確認された.